24 Dec, 2024
6 mins read

Nonalcoholic Steatohepatitis Therapeutics Market to be Worth US$ 20.27 Bn by 2025 – TMR

Non-alcoholic Steatohepatitis Therapeutics Market Non-alcoholic steatohepatitis is a type of liver disease diagnosed in people who are non-alcoholic or consume alcohol in very low amount. Non-alcoholic steatohepatitis (NASH) is one of the commonly diagnosed liver diseases. The diseases is also referred to as silent liver disease. Fat deposition in liver along with inflammation is one […]